Ribocure Pharmaceuticals Ab
Clinical trials sponsored by Ribocure Pharmaceuticals Ab, explained in plain language.
-
New heart drug enters Mid-Stage safety testing
Disease control OngoingThis study is testing a new drug called RBD4059 to see if it is safe and might help people with stable coronary artery disease, a condition where the heart's arteries are narrowed. About 30 adults will receive either the drug or a placebo (inactive substance) through injections u…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New drug trial targets Hard-to-Treat hepatitis d
Disease control OngoingThis study is testing whether RBD1016 injections can reduce hepatitis D virus levels in people with chronic infection. Fourteen adults will receive either the drug or a placebo for comparison, with regular checkups over 60 weeks. The main goal is to see if the treatment lowers vi…
Phase: PHASE2 • Sponsor: Ribocure Pharmaceuticals AB • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC